MC-VC-PAB-NH2 incorporates a maleimide-capable moiety, a Val-Cit protease-cleavable linker, and a para-aminobenzyl self-immolative spacer. The construct is frequently evaluated as a modular unit in conjugate and prodrug design. Researchers quantify cleavage kinetics and payload-release profiles in enzymatic systems. Applications include linker-technology optimization, targeted-delivery modeling, and protease-mechanism studies.
CAT No: R2710
CAS No:1616727-20-8
Synonyms/Alias:MC-VC-PAB-NH2;1616727-20-8;SCHEMBL15868007;{4-[(2S)-5-(carbamoylamino)-2-[(2S)-2-[6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido]-3-methylbutanamido]pentanamido]phenyl}methyl N-(2-aminoethyl)carbamate;AKOS040756930;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]methyl N-(2-aminoethyl)carbamate;DA-55296;HY-136132;CS-0119676;
1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
4. Cationic cell-penetrating peptides are potent furin inhibitors
5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More